102¦~2¤ë¸¹ ¹D ªk ªk °T (250)

DEEP & FAR

 

 

±M§Q¤§¦A¼f¬d°µ¬°¶D³^¤§´À¥N¤è®×(¥|)

 

½²Â×¼w ¸ê²`±M§Q¤uµ{®v

¥æ³q¤j¾Ç¤g¤ì¤uµ{¨t

 

¦b¶D³^¤¤´£¥X©Ò¦³µL®Äª§½×¤§«e¡A»Ý­n¦Ò¼{ªº¨ÆÀ³«Y¥Ó½Ð¤@¥ó³æ¤è­±©Î¨â³y¶¡¤§¦A

¼f¬d¶D³^ªº§Q¯q¡C²Î­pÅã¥Ü¡G³æ¤è­±¤Î¨â³y¶¡¤§¦A¼f¬d¶D³^³£·|¬O¦³®Äªº¡A¥B´£¥X¦A¼f

¬d¸û¶D³^«Y¨å«¬¦a¤£©ù¶Q¦h¤F¡C

¡·    ¶D³^¤§²´

¤@²Õ­ì§i¡A¥]¬A¬ü°ê¤½¥Á¦Û¥ÑÁp·ù(ACLU)¤Î¤½²³±M§Q°òª÷·|(PUB PAT)¡A¦b¬ü°ê¯Ã

¬ù«n°Ï¦a¤èªk°|´£¥X¤@¥ó¶D³^ÁnºÙ¡G»P¯Ý³¡¤Î§Z±_Àù¬ÛÃö¤§°ò¦]±M§Q«Y¹H¤Ï¾Ëªk¥BµL®Ä

ªº¡C¸Ó¶D³^¤§¼ÐÃD¬OAssociation for Molecular Pathology et al. v. U.S. Patent and Trademark et

al.¡A¦Ó¥B¹ïµÛ¸ÓU.S. Patent and Trademark¡BMyriad Genetics¡B¤ÎUniversity of Utah Research

Foundation¦Ó´£¥X¡C

¦b2010¦~¤T¤ëªº¤@­Ó§P¨M¡A¸Ó¦a¤èªk°|¨M©w¡G¦]¬°¡§¤ÀÂ÷ªºDNA¡¨¤§½Ð¨D¶µ¥]§t

¦ÛµM¬Éªº²£ª«¡A¨Ì¾Ú¬ü°ê±M§Qªk²Ä101±øMyriad¤§½Ð¨D¶µ«Y«D¾A®æªº±M§Q¡C¥Ñ©ó¸Ó³Ì°ª

ªk°|¤§1980¸¹§P¨M¡§¤Z«Y¥Ñ¤H¦b¤Ó¶§¤U©Ò¬°¤§¥ô¦ó¨Æª«¡¨¬O¥i±M§Qªº¹ê½è¤º®e¡A¤ÀÂ÷

ªºDNA¤w¦¨¬°³\¦h±M§Q¤§¥DÃD¡C¸Ó¥Íª«§Þ³N¤u·~¾Ö¦³¶W¹L40,000°ò¦]±M§Q¡C¦¹®×¨Ò¦b

®Ö­ã°ò¦]¤§±M§QÅvªº«á­±ªº¬Fµ¦¤W§l¤Þª`·N¡A¥H¤Î¹ï¸Ó¥Íª«§Þ³N¤u·~¥i¯à¦³¤@ºØ¹ê½èªº

½ÄÀ»¡C

Myriad¦b2010¦~6¤ë¹ï¬ü°êÁp¨¹¨µ°j¤W¶Dªk®x´£¥X¤@¥÷¤W¶D¡A¨ÃÀH«á¸É²z¥Ñ¡CÃö
©ó¥ô¦ó±q¦ÛµM¬É¤ÀÂ÷ªº¤Æ¦Xª«¬O§_«Y¥i±M§Qªº¹ê½è¤º®e¡A¸Ó¨M©w¥i¯àªø»·ªº¼vÅT¡C